Publication

Congrats to Dr Xue Liu for her new paper in BioRxiv preprint website titled: “Genome-wide CRISPRi screens reveal the essentialome and determinants for susceptibility to dalbavancin in Staphylococcus aureus”

Congrats to Dr Xue Liu for her new paper in BioRxiv preprint website titled: “A conserved antigen induces respiratory Th17-mediated serotype-independent protection against pneumococcal superinfection” https://www.biorxiv.org/content/10.1101/2023.07.07.548156v1.article-info

Congrats to Dr Xue Liu for involving in the latest publication on the Int. J. Antimicrob. Agents “The usnic acid derivative peziculone targets cell walls of Gram-positive bacteria revealed by high-throughput CRISPRi-seq analysis”

Congrats to Dr Xue Liu and Yongkui Chen for involving in the latest publication on the Lancet Microbe “Distribution and spread of the mobilised RND efflux pump gene cluster tmexCD-toprJ in clinical Gram-negative bacteria: a molecular epidemiological study”

In this work,

Congrats to Dr YuZhang He for the latest publication on Frontiers Pharmacology “A Cyclic Adenosine Monophosphate Response Element-binding Protein Inhibitor Enhances the Antibacterial Activity of Polymyxin B by Inhibiting the ATP hydrolyzation activity of CrrB”. In this work, Dr He assisted the collaborator to prove that the P151L mutation of CrrB mediates the resistance of bacteria to the enhancement of 666-15 by precise genome editing of Klebsiella pneumoniae.

Vincent and Xue’s paper titled CRISPRi-seq for genome-wide fitness
quantification in bacteria is published in Nature Protocol! Congrats!!!